Amplification of MET expression in some cancers [38] would affect interaction of HGF with proteins in the senescence-associated secretory phenotype [39], as would the stage of angiogenesis in the growth, carcinogenesis and metastasis of tumors in response to Sema3A signaling [40, 41]. The gene discussed is MET; the disease is cancer.